Skip to main content
. Author manuscript; available in PMC: 2014 Nov 25.
Published in final edited form as: Pediatr Blood Cancer. 2013 Jan 17;60(5):783–790. doi: 10.1002/pbc.24368

Fig. 3.

Fig. 3

Temozolomide dose-response activity against solid tumor xenografts. Individual tumor volume graphs are shown for KT-10, CHLA-258, Rh28, and GBM2 for control (untreated) and treated tumor groups. Relative tumor volume graphs are shown in the right panels: (➂) Control; (➄) 22 mg/kg; (➉) 44 mg/kg; (➀) 66 mg/kg.